reggie78: Saw that article quite some time ago. Of course, the BIG PHARMA's have IMMENSE "fire-power for deal-making" at their disposal in 2022!!
And because their "in-house" activities are often not bringing about the necessary/expected results, it will be much, much cheaper for them to BUY outside - especially in the case of already POSITIVE (!!) Phase III results at hand. Often, those Big Pharma companies do buy already after positive phase II results !
Just wonder which one(s) among those BIG PHARMAS will have the biggest interest in the field that NEU is operating in??
Comments most welcome as usual!
wasa
ROW, page-6
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |